Skip to main content
Loading

Spotlight Presentation: Innovative Production and Engineering Strategies for Fab, ScFv & VHH

17 Jun 2024
Salon H
Target Selection , Lead Identification & Optimization , Formats & Scaffolds , Bi/Multispecifics , Emerging Technologies
Spotlight Presentation: Innovative Production and Engineering Strategies for Fab, ScFv & VHH
Antibody fragments like Fab, ScFv, and VHH are emerging stars in antibody drug development, utilized both as standalone molecules and as building blocks of bispecific antibodies. However, their production and engineering face numerous challenges, including issues related to yield, purity, throughput, and stability. In this webinar, we will unveil innovative strategies to overcome these challenges, tailored to the distinctive characteristics of Fab, ScFv, and VHH. We’ll provide key insights into molecular design, high-titer CHO transient and stable production and effective purification methods to accelerate your development of antibody fragments.
Industry Expert
Sundee Dees, Business Development – Research Services - WuXi Biologics